Q32 Bio Inc. – NASDAQ:QTTB
Q32 Bio stock price today
Q32 Bio stock price monthly change
Q32 Bio stock price quarterly change
Q32 Bio key metrics
Market Cap | 41.90M |
Enterprise value | N/A |
P/E | N/A |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | N/A |
PEG ratio | N/A |
EPS | -26.07 |
Revenue | N/A |
EBITDA | -94.50M |
Income | -83.08M |
Revenue Q/Q | -100% |
Revenue Y/Y | -88.96% |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeQ32 Bio stock price history
Q32 Bio stock forecast
Q32 Bio financial statements
$79.67
Potential upside: 4277.28%
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 354K | -35.04M | -9899.44% |
|---|---|---|---|
| Sep 2023 | 0 | -32.95M | |
| Dec 2023 | 0 | -16.11M | |
| Mar 2024 | 0 | 1.02M |
| Jun 2023 | 169337000 | 49.96M | 29.5% |
|---|---|---|---|
| Sep 2023 | 53769000 | 210.22M | 390.97% |
| Dec 2023 | 306119000 | 233.12M | 76.16% |
| Mar 2024 | 152334000 | 103.56M | 67.99% |
| Jun 2023 | -23.66M | 61.00M | 2K |
|---|---|---|---|
| Sep 2023 | -24.94M | -22.76M | 18K |
| Dec 2023 | -21.57M | 31.71M | 14K |
| Mar 2024 | -14.55M | 97K | 99.34M |
Q32 Bio alternative data
| Jun 2024 | 39 |
|---|---|
| Jul 2024 | 39 |
Q32 Bio other data
| Period | Buy | Sel |
|---|---|---|
| Mar 2024 | 0 | 343 |
-
What's the price of Q32 Bio stock today?
One share of Q32 Bio stock can currently be purchased for approximately $1.82.
-
When is Q32 Bio's next earnings date?
Unfortunately, Q32 Bio's (QTTB) next earnings date is currently unknown.
-
Does Q32 Bio pay dividends?
No, Q32 Bio does not pay dividends.
-
How much money does Q32 Bio make?
Q32 Bio has a market capitalization of 41.90M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 82.62% to 1.16M US dollars.
-
What is Q32 Bio's stock symbol?
Q32 Bio Inc. is traded on the NASDAQ under the ticker symbol "QTTB".
-
What is Q32 Bio's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Q32 Bio?
Shares of Q32 Bio can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Q32 Bio have?
As Jul 2024, Q32 Bio employs 39 workers.
-
When Q32 Bio went public?
Q32 Bio Inc. is publicly traded company for more then 7 years since IPO on 28 Mar 2018.
-
What is Q32 Bio stock forecast & price target?
Based on 3 Wall Street analysts` predicted price targets for Q32 Bio in the last 12 months, the avarage price target is $79.67. The average price target represents a 4277.28% change from the last price of $1.82.
Q32 Bio company profile:
NASDAQ
42
Biotechnology
Healthcare
Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body’s first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function. ADX-097, the lead product candidate from Q32’s complement inhibitor platform, is a humanized anti-C3d monoclonal antibody fusion protein.
,
:
ISIN: US7469641051
:
